Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy-Reference-Cited by-同舟云学术

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Published:2021-11 Issue:11 Volume:2 Page:100449
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Li Yan-Ruide,Zhou Yang,Kim Yu Jeong,Zhu Yanni,Ma Feiyang^ORCID,Yu Jiaji,Wang Yu-Chen,Chen Xianhui,Li Zhe,Zeng Samuel,Wang Xi,Lee Derek,Ku Josh,Tsao Tasha^ORCID,Hardoy Christian^ORCID,Huang Jie,Cheng Donghui,Montel-Hagen Amélie,Seet Christopher S.,Crooks Gay M.,Larson Sarah M.,Sasine Joshua P.,Wang Xiaoyan,Pellegrini Matteo^ORCID,Ribas Antoni,Kohn Donald B.^ORCID,Witte Owen,Wang Pin^ORCID,Yang Lili^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference90 articles.

1. Adoptive immunotherapy for cancer: harnessing the T cell response;Restifo;Nat. Rev. Immunol.,2012

2. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology;Kalos;Immunity,2013

3. Adoptive immunotherapy for cancer or viruses;Maus;Annu. Rev. Immunol.,2014

4. Programming CAR-T cells to kill cancer;Labanieh;Nat. Biomed. Eng.,2018

5. Chimeric antigen receptor T-cell therapies for multiple myeloma;Mikkilineni;Blood,2017

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Chimeric Antigen Receptor-engineered Invariant Natural Killer T Cells: Therapeutic Strategies for Cancer and the Tumor Microenvironment;Current Pharmaceutical Biotechnology;2024-11

2. Thymic development of human natural killer T cells: recent advances and implications for immunotherapy;Frontiers in Immunology;2024-08-29

3. Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy;Frontiers in Immunology;2024-08-19

4. Traversing the bench to bedside journey for iNKT cell therapies;Frontiers in Immunology;2024-08-07

5. Engineering M1 macrophages with targeting aptamers for enhanced adoptive immunotherapy by modifying the cell surface;Biomedicine & Pharmacotherapy;2024-08